🔗 Share this article

The prestigious award in Physiology or Medicine was granted for transformative findings that illuminate how the body's defense network targets harmful pathogens while sparing the body's own cells.

Three renowned researchers—from Japan Shimon Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—share this accolade.

The work identified unique "sentinels" within the defense system that eliminate malfunctioning defense cells capable of harming the body.

The discoveries are now enabling new therapies for immune disorders and malignancies.

These winners will divide a monetary award valued at 11m SEK.

Decisive Findings

"Their work has been essential for comprehending how the body's defenses functions and the reason we don't all suffer from serious self-attack conditions," commented the chair of the Nobel Committee.

The team's research address a fundamental question: In what way does the immune system defend us from countless infections while keeping our healthy cells unharmed?

The body's protection system employs white blood cells that search for signs of disease, even viruses and germs it has not met before.

Such cells utilize detectors—called recognition units—that are produced by chance in countless combinations.

That gives the defense network the capacity to fight a broad range of invaders, but the unpredictability of the process unavoidably creates white blood cells that may attack the host.

Protectors of the Immune System

Researchers previously understood that a portion of these problematic defense cells were destroyed in the immune organ—the site where immune cells mature.

This year's Nobel Prize recognizes the identification of regulatory T-cells—described as the body's "security guards"—which patrol the system to disarm any immune cells that assault the body's own tissues.

It is known that this process malfunctions in autoimmune diseases such as type-1 diabetes, MS, and RA.

The Nobel panel added, "The findings have established a new field of research and spurred the creation of new treatments, for example for cancer and immune disorders."

In cancer, T-regs block the system from attacking the tumor, so research are focused on reducing their quantity.

In autoimmune diseases, trials are exploring boosting T-reg cells so the body is no longer being harmed. A comparable approach could also be effective in reducing the chances of organ transplant rejection.

Innovative Experiments

Professor Shimon Sakaguchi, from a Japanese institution, performed experiments on rodents that had their thymus removed, leading to self-attack conditions.

He demonstrated that introducing defense cells from other animals could prevent the illness—suggesting there was a mechanism for blocking defenders from harming the body.

Mary Brunkow, from the Institute for Systems Biology in Seattle, and Dr. Ramsdell, now at a biotech firm in a California city, were studying an genetic autoimmune disease in rodents and people that resulted in the identification of a genetic factor critical for how T-regs function.

"Their pioneering research has revealed how the body's defenses is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," said a prominent biological science specialist.

"This work is a striking example of how basic biological study can have far-reaching implications for public health."